Product Information
FONDAPARINUX 7.5 MG/0.6 ML SYR is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $42.8089 per ML under NDC 70710151606. Its NADAC has been published 250 times since Feb 17, 2021.
FDA first approved this application on Nov 14, 2018. Its Orange Book therapeutic-equivalence code is AP.
Strength
7.5 mg/.6mL
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710151606
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA208615FDA Approved
11/14/2018
TE Code
AP
On Market Since
2/6/2019
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has been published 250 times since Feb 17, 2021, and over the history we have for it it has declined 36.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $42.8089 per ML |
|---|---|
| All-time high | $68.7043 (Dec 15, 2021) |
| All-time low | $34.9283 (Jun 19, 2024) |
| 52-week high | $43.4533 |
| 52-week low | $38.5660 |
| Median price | $49.0044 |
| Average price | $50.8441 |
| Largest weekly change | +27.9% (Jul 17, 2024) |
| Weeks tracked | 250 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fondaparinux sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor Xa Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FONDAPARINUX 7.5 MG/0.6 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 7.5 MG/0.6 ML SYR, manufactured by Zydus Pharmaceuticals (USA) Inc., is $42.8089 per ML (NDC 70710151606), effective Sep 30, 2026.
How has the price of FONDAPARINUX 7.5 MG/0.6 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has declined 36.8%. It has been tracked across 250 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 7.5 MG/0.6 ML SYR?
Since Feb 17, 2021, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has ranged from a low of $34.9283 (Jun 19, 2024) to a high of $68.7043 (Dec 15, 2021), with a median of $49.0044 per ML.
Are there cheaper alternatives to FONDAPARINUX 7.5 MG/0.6 ML SYR?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FONDAPARINUX 7.5 MG/0.6 ML SYR, is $20.9233 per ML — about 51% below FONDAPARINUX 7.5 MG/0.6 ML SYR.
Who manufactures FONDAPARINUX 7.5 MG/0.6 ML SYR?
FONDAPARINUX 7.5 MG/0.6 ML SYR (NDC 70710151606) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.